Clinical Utility and Cost Savings in Predicting Inadequate Response to Anti-TNF Therapies in Rheumatoid Arthritis

Journal article

Open access

Peer reviewed

Martin J. Bergman, Alan J. Kivitz, Dimitrios A. Pappas, Joel M. Kremer, Lixia Zhang, Anna Jeter and Johanna B. Withers

Rheumatology and therapy, v 7(4), pp 775-792

14 Aug 2020

PMID: 32797404

Files and links (1)

url

https://doi.org/10.1007/s40744-020-00226-3View

Published, Version of Record (VoR)CC BY-NC V4.0, Open

Anti-TNF therapies

Budget impact

Clinical utility

Original Research

Precision medicine

Rheumatoid arthritis

6 Record Views

23 citations in Scopus

Title: Clinical Utility and Cost Savings in Predicting Inadequate Response to Anti-TNF Therapies in Rheumatoid Arthritis
Creators: Martin J. Bergman - Drexel University
Alan J. Kivitz - Altoona Center for Clinical Research
Dimitrios A. Pappas - Columbia University
Joel M. Kremer - Albany Medical Center Hospital
Lixia Zhang - Scipher Medicine Corporation, 221 Crescent St., Suite 103A, Waltham, MA, USA.
Anna Jeter - Scipher Medicine Corporation, 221 Crescent St., Suite 103A, Waltham, MA, USA.
Johanna B. Withers - Scipher Medicine Corporation, Waltham, USA
Publication Details: Rheumatology and therapy, v 7(4), pp 775-792
Publisher: Springer Healthcare
Grant note: ;
Resource Type: Journal article
Language: English
Academic Unit: Medicine (Graduate)
Web of Science ID: WOS:000559685800001
Scopus ID: 2-s2.0-85108323099
Other Identifier: 991019168072804721

This publication has contributed to the advancement of the following goals:

Data related to this publication, from InCites Benchmarking & Analytics tool: